$2.55T
Total marketcap
$181.52B
Total volume
BTC 50.01%     ETH 15.86%
Dominance

Bio-Techne TECH Stock

71.88 USD {{ price }} -0.882514% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
11.3B USD
LOW - HIGH [24H]
71.07 - 72.87 USD
VOLUME [24H]
942.46K USD
{{ volume }}
P/E Ratio
51.71
Earnings per share
1.39 USD

Bio-Techne Price Chart

Bio-Techne TECH Financial and Trading Overview

Bio-Techne stock price 71.88 USD
Previous Close 74.87 USD
Open 74.8 USD
Bid 0 USD x 1000
Ask 0 USD x 800
Day's Range 74.68 - 76.63 USD
52 Week Range 68 - 99.34 USD
Volume 1.26M USD
Avg. Volume 1.04M USD
Market Cap 12.06B USD
Beta (5Y Monthly) 1.256338
PE Ratio (TTM) 45.601192
EPS (TTM) 1.39 USD
Forward Dividend & Yield 0.32 (0.42%)
Ex-Dividend Date May 12, 2023
1y Target Est 101.07 USD

TECH Valuation Measures

Enterprise Value 12.1B USD
Trailing P/E 45.601192
Forward P/E 31.788382
PEG Ratio (5 yr expected) 3.64
Price/Sales (ttm) 10.734373
Price/Book (mrq) 6.378851
Enterprise Value/Revenue 10.772
Enterprise Value/EBITDA 35.157

Trading Information

Bio-Techne Stock Price History

Beta (5Y Monthly) 1.256338
52-Week Change -6.33%
S&P500 52-Week Change 20.43%
52 Week High 99.34 USD
52 Week Low 68 USD
50-Day Moving Average 81.22 USD
200-Day Moving Average 78.96 USD

TECH Share Statistics

Avg. Volume (3 month) 1.04M USD
Avg. Daily Volume (10-Days) 953.66K USD
Shares Outstanding 157.44M
Float 155.97M
Short Ratio 2.97
% Held by Insiders 0.89%
% Held by Institutions 96.50%
Shares Short 3.04M
Short % of Float 2.50%
Short % of Shares Outstanding 1.92%

Dividends & Splits

Trailing Annual Dividend Rate 0.32
Trailing Annual Dividend Yield 0.42%
5 Year Average Dividend Yield 49.00%
Payout Ratio 0.1908
Last Split Factor 4:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 24.14%
Operating Margin (ttm) 24.80%
Gross Margin 68.16%
EBITDA Margin 30.64%

Management Effectiveness

Return on Assets (ttm) 7.11%
Return on Equity (ttm) 15.09%

Income Statement

Revenue (ttm) 1.12B USD
Revenue Per Share (ttm) 7.16 USD
Quarterly Revenue Growth (yoy) 1.30%
Gross Profit (ttm) 758.09M USD
EBITDA 344.29M USD
Net Income Avi to Common (ttm) 271.22M USD
Diluted EPS (ttm) 1.68
Quarterly Earnings Growth (yoy) 15.59%

Balance Sheet

Total Cash (mrq) 157.2M USD
Total Cash Per Share (mrq) 1 USD
Total Debt (mrq) 473.99M USD
Total Debt/Equity (mrq) 25.08 USD
Current Ratio (mrq) 4.045
Book Value Per Share (mrq) 12.01

Cash Flow Statement

Operating Cash Flow (ttm) 273.72M USD
Levered Free Cash Flow (ttm) 225.2M USD

Profile of Bio-Techne

Country United States
State MN
City Minneapolis
Address 614 McKinley Place N.E.
ZIP 55413
Phone 612 379 8854
Website https://www.bio-techne.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 3000

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It has strategic partnership with Lunaphore Technologies S.A. to develop automated same-slide spatial multiomics solution. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Q&A For Bio-Techne Stock

What is a current TECH stock price?

Bio-Techne TECH stock price today per share is 71.88 USD.

How to purchase Bio-Techne stock?

You can buy TECH shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bio-Techne?

The stock symbol or ticker of Bio-Techne is TECH.

Which industry does the Bio-Techne company belong to?

The Bio-Techne industry is Biotechnology.

How many shares does Bio-Techne have in circulation?

The max supply of Bio-Techne shares is 157.19M.

What is Bio-Techne Price to Earnings Ratio (PE Ratio)?

Bio-Techne PE Ratio is 51.71222700 now.

What was Bio-Techne earnings per share over the trailing 12 months (TTM)?

Bio-Techne EPS is 1.39 USD over the trailing 12 months.

Which sector does the Bio-Techne company belong to?

The Bio-Techne sector is Healthcare.

Bio-Techne TECH included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
S&P 500 (Yahoo.com) GSPC 5149.42 USD
+0.63
2.4B USD 5145.47 USD 5175.6 USD 2.4B USD
S&P 500 INDEX SPX 5149.42 USD
+0.63
2.39B USD 2.39B USD
Dow Jones U.S. Biotechnology In DJUSBT 2844.59 USD
+0.08
79.29M USD 2839.63 USD 2860.51 USD 79.29M USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Nasdaq Next Generation 100 Inde NGX 1138.09 USD
-0.13
1137.73 USD 1146.36 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD
NASDAQ Q 50 NXTQ 737.55 USD
-0.27
737.3 USD 745.3 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
NASDAQ Biotechnology Total Retu XNBI 4654.3 USD
-0.65
4652.69 USD 4696.7 USD